Basics Tenaya Therapeutics, Inc. IPO Date: June 30, 2021 Sector: Healthcare Industry: Biotech Market Cap: $220.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.67% Avg Daily Range (30 D): $0.05 | 5.28% Avg Daily Range (90 D): $0.04 | 4.96% Institutional Daily Volume Avg Daily Volume: .9M Avg Daily Volume (30 D): 3.23M Avg Daily Volume (90 D): 2.5M Trade Size Avg Trade Size (Sh.): 230 Avg Trade Size (Sh.) (30 D): 483 Avg Trade Size (Sh.) (90 D): 446 Institutional Trades Total Inst.Trades: 105 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $2.86M Avg Inst. Trade (90 D): $1.9M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.17M Avg Closing Trade (30 D): $2.86M Avg Closing Trade (90 D): $1.9M Avg Closing Volume: 595.55K     News Aug 31, 2025 @ 2:15 PM Tenaya Therapeutics Presents Interim Data from MyC... Source: Tenaya Therapeutics Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc. Jun 18, 2024 @ 8:30 PM Tenaya Therapeutics to Participate at the TD Cowen... Source: Tenaya Therapeutics, Inc. May 14, 2024 @ 8:05 PM Tenaya Therapeutics Reports First Quarter 2024 Fin... Source: Tenaya Therapeutics, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.95 $-.14 $-.24 Diluted EPS $-.95 $-.14 $-.24 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -99.62M $ -23.28M $ -26.86M Operating Income / Loss $ -102.98M $ -24.08M $ -27.54M Cost of Revenue $ $ $ Net Cash Flow $ 4.54M $ 8.9M $ 49.45M PE Ratio